Rebif
Rebif - Basic Information
- GN: Interferon beta-1a
- Con: Multiple sclerosis (ms)
- Cla: information not available
Rebif - Indication of :
Rebif belongs to a class of medications called interferons. It is used to treat patients with relapsing or remitting forms of multiple sclerosis (MS). This a chronic and disabling disease of the central nervous system thought to be caused by the bodys immune system attacking cells of the brain and spinal cord and leading to demyelination (removal of the electrical conducting layer of nerve cells). It can have various affects on vision, sensation, speech, mood and muscular strength. If left untreated the disease can lead to severe impairments in mobility. Rebif is used only to treat the relapsing form where patients have transient attacks of symptoms. Generally if you experience more than two attacks per year you will be considered for this medication. Rebif has been proven effective in reducing the frequency of attacks and delaying the progression of disability. Several clinical trials and experience with the drug in other countries have also confirmed its safety along with its efficacy.
Rebif - Details